ww@㎕w q򗝊w



1.        Ueda H:Lysophosphatidic acid signaling is involved in the development and maintenance of neuropathic pain and fibromyalgia.the 18th World Congress of Basic and Clinical Pharmacology(WCP2018).2018,s

2.        Ueda H:Recent Advances in Neurobiology of Prothymosin 1 Non-Classical Release and New Receptor System.5th International Symposium on Thymosins in Health and Disease.2017,Washington(USA)

3.        Ueda H,Neyama H:Brain mechanisms of LPA-signaling in the central pain.2017 FASEB .2017,New Orlean(USA)

4.        Ueda H:Fibromyalgia in mice.GLORIA symposium(glial-opioid-receptor-interface in analgesia symposium).2016,Strasbourg(France)

5.        Ueda H:Brain Mechanisms and Pharmacotherapy in Generalized Chronic Pain Model Similar to Fibromyalgia in Mice.Fibromyalgia Research Symposium 2016 in Nagasaki(FRS 2016NAGASAKI).2016,Nagasaki(Japan)

6.        Ueda H:Neuropathic pain initiation and maintenance: the role of glialmediated LPA signaling in neuropathic pain models .16th World Congress on Pain@iIASP).2016,Yokohama(Japan)

7.        Ueda H:Lysophosphatidic acid: a biochemical signature for neuropathic pain.16th World Congress on Pain iIASP).2016,Yokohama(Japan)

8.        Ueda H:Pharmacotherapeutic innovation using a novel experimental fibromyalgia model in mice.Pain Mechanisms and Therapeutics Conference.2016,Sicily( Italy)

9.        Ueda H:Pharmacotherapeutic innovation against LPA-mediated chronic pain.14th International Conference .2015,BudapestiHungaryj

10.     Ueda H:LPA as chemical signature of neuropathic pain mechanisms and therapeutic innovation.FASEB Science Research Conference.2015,Banff(Canada)

11.     Ueda H, Nagai J Mukae T: Differential regulation of endocannabinoids and LPA production in inflammatory and neuropathic pain.6th international conference on Phospholipase A2 and Lipid Mediators. 6th international conference on Phospholipase A2 and Lipid MediatorsiPLM2015j.2015,

12.     Ueda H:Prothymosin alpha-derived Hexapeptide and is analogs ameliorate blood-brain barrier dysfunction following cerebral ischemia in mice.FOURTH INTERNATIONAL SYMPOSIUM ON THYMOSINS IN HEALTH AND DISEASE.2014,Roma(Italy)

13.     Ueda H:Epigenetic mechanisms for pain: A novel approach to pain treatment.IASP 15th World Congress on Pain.2014,Buenos Aires(Argentine)

14.     Ueda H:My Phenotypic Switch Studies.CaltechNeuroimmunology Symposium.2014,Los Angeles(USA)

15.     Ueda H, Nagai J, Mukae T, Matsushita Y:Blockade of lysophosphatidic acid receptor signaling completely cures the established chronic pain.13th Int1l Conference on BioactiveLipids in Cancer, Inflammation and Related Diseases.2013,San Juan(Puerto Ricoj

16.     Ueda H, Nagai J, Mukae T:Central pain and lysophosphatidic acid.FASEB SCIENCE RESEARCH CONFERENCE.2013,kC

17.     Ueda H:Lysophosphatidic acid: Chemical signature of neuropathic pain.The 92nd Annual Meeting of the German Physiological Society.2013,Heidelberg(Germany )

18.     Ueda H:Repeated challenges of systemic mirtazapine cause permanent pain relief in mouse experimental fibromyalgia model.IASP 14th World Congress on Pain .2012,Milan,(Italy)

19.     Ueda H:Epigenetic silencing of sodium channel, TRP channels and opioid receptor in neuropathic pain.IASP 14th World Congress on Pain .2012,Milan(Italy)

20.     Ueda H:Prothymosin alpha: its mechanisms for non-vesucular release and receptor in central nervous system.THIRD INTERNATIONAL SYMPOSIUM ON THYMOSINS IN HEALTH AND DISEASE.2012, Washingtonl(USA).

21.     Ueda HProthymosin : a novel neuroprotetive polypeptide against ischemic damages.2011, Taiwan-Japan Joint Symposium on Cell Signaling and Gene Regulation.2011,k(p)

22.     Ueda H, Nagai J, Lin Ma, Yano R, Shinohara K, Shinagawa A, and Taira K:PA receptor-mediated amplification of LPA biosynthesis and demyelination underlie the initiation mechanisms for neuropathic pain.The 9th IASP Research Symposium.2011,C()

23.     Ueda H, Nagai J, Ma L, and Taira K:Feed-forward amplification of LPA3 receptor-mediated LPA production via microglia in the initiation of neuropathic pain.FASEB SUMMER@RESEARCH CONFERENCE- Lysophospholipid Mediators in Health & Disease.2011,Lucca(Italy)

24.     Ueda H:Rescue of specific promotor-regulated mu-opioid and nmda receptor gene into pag of k/o mice - pain species-specific brain loci for morphine analgesia and tolerance..IASP The 13th World Congress on Pain..2010,Montreal(Canada)

25.     Ueda H: Epigenetic control of opioid receptor gene expression in neuropathic pain model,INRC. 2010,Malmo (Sweden)

26.     Ueda H:Identification of prothymosin alpha, the necrosis-apoptosis switch molecule in ischemic culture of cortical neuron.           Second International Symposium on Thymosins in Health and Disease,2009,Catania(Italy)

27.     Ueda H:Neural pathological roles for receptor mediated LPA signaling.FASEB@SUMMER@RESEARCH@CONFERENCE, 2009,Arizona(USA)

28.     Ueda H: Molecular mechanisms of neuropathic pain.Opioids Past and Future: relevance to pain and addiction.2007,Salamanca (Spain)

29.     Ueda H: Molecular mechanisms underlying neuropathic pain - identification of related nociceptive fibers and the initiator, lysophosphatidic acid.The Study of Pain's Annual "Pain Day".2006, Toronto(Canada)

30.     Ueda H: Molecular mechanisms of neuropathic pain - lysophosphatidic acid as the initiator.@The International Conference -Synapses-Memory-Drug Addiction-Pain-.2006, Toronto(Canada)

31.     Ueda H:Locus-specific rescue of opioid receptor.37th International Narcotic Research Conference Symposium,2006, St.Paul(USA)

32.     Ueda H:Lysophosphatidic acid and neuropathic pain. The 2nd Asian Pain Symposium.2004, Seoul(Korea)

33.     Ueda H: New approaches to visualize opioid tolerance and dependence. The 2004 European Opioid Conference.2004, Visegrad(Hungary)

34.     Ueda H: Locus-specific role of anti-opioid system in morphine tolerance and dependence.
34th International Narcotic Research Conference Symposium (Adaptations to chronic opiates:from celllar events to in vivo responses).2003 Perpignan (France)

35.     Ueda HFDistinct roles of ppN/OFQ-derived peptides in pain control International Narcotic Research Conference, 2001.Helsinki( Finland)

36.     Ueda HFEnhanced spinal nociceptin system is involvd in thd development of morphine tolerance and dependence.International Narcotic Research Conference.2000, Seattle (USA)

37.     Ueda H, Inoue MFIn vivo involvement of nociceptin in morphine-induced tolerance and dependence.The 8th Southeasr Asian-Western Pacific Regional Meeting of pharmacologists.1999,k(p)

38.     Ueda HFIn vivo signal transduction in mice lacking receptor genes.
International Narcotic Research Conference. 1998, Garmisch-Partenkirchen( Germany)

39.     Ueda HFSignal transduction of opioid, kyotorphin, nociceptin/orphanin FQ and sigma receptors.Symposium on Opioid Pharmacology.1997, Chanju(Korea)

40.     Ueda HFEvidence for kappa-opioid receptor inhibition of G-protein activity in reconstitution experiments.nternational Narcotic Research Conference.1992, Keystone, Denver(USA)

41.     Takagi H, Satoh M, Shiomi H, Akaike A, Ueda H, Kawajiri S, Yamamoto M and AmanoH:Identification of a new opioid peptide from the bovine brain and its mechanism of action.International Narcotic Research Conference.1979, Boston(USA)